INTRODUCTION AND OBJECTIVES:
In patients with primary aldosteronism (PA), excessive aldosterone causes glomerular hyperfiltration, which can be associated with increase in glomerular filtration ratio (GFR). After treatment of PA, correction of hyperfiltration may decrease GFR. Therefore, decrement in GFR can be a clinically significant problem after treatment of PA. The aim of this study was to determine the prevalence of renal deterioration and new onset chronic kidney disease (CKD), and identify the predictors of decreasing estimated GFR (eGFR) after laparoscopic adrenalectomy for aldosteroneproducing adenoma.
METHODS: In our institution, 64 patients underwent laparoscopic adrenalectomy for PA between 2001 and 2015. Of them, 41 patients who received postoperative surveillance for more than 12 months were included in this retrospective study. Preoperative parameters including age, sex, duration of hypertension, eGFR, the ratio of plasma aldosterone (pg/mL) to plasma renin activity (ng/mL/ hr) ratio (ARR), tumor size and operation time were evaluated to determine risk factors for postoperative deterioration of eGFR (>25% decrement from preoperative level) and new onset CKD (eGFR <60 ml/min/1.73m2).
RESULTS: Median followup was 58 months (range 12-187). Mean preoperative eGFR was significantly decreased from 73.6 AE 19.7 ml/min/1.73m2 at baseline to 61.0 AE 18.9 ml/min/1.73m2 at the latest followup (p<0.01). Fifteen patients (36.6%) showed postoperative deterioration of eGFR. ARR was the only significant predictive factor for postoperative deterioration of eGFR. Using a cutoff point of 2000, sensitivity and specificity were 62.5% and 77.2%, respectively. Excluding 11 patients who had CKD before operation, 13 (43.3%) of 30 patients developed new onset CKD after operation. We could not determine a significant predictor for postoperative new onset CKD.
CONCLUSIONS: Postoperative renal deterioration is prevalent in patients with PA. High ARR may be associated with the degree of glomerular hyperfiltration and irreversible renal damage and is a predictive factor of eGFR decrement after removal of adenoma. Postoperative surveillance of renal function and management of CKD are essential in patients who underwent adrenalectomy for PA.
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SUPER-SELECTIVE ADRENAL VENOUS SAMPLING IS USEFUL FOR EVALUATING CORTISOL-PRODUCING ADENOMA Koshiro Nishimoto*, Hidaka, Japan; Kohzoh Makita, Tokyo, Japan; Kanako Kitamoto-Kiriyama, Yokohama, Japan; Tsugio Seki, Colton, CA; Masanori Yasuda, Masafumi Oyama, Hidaka, Japan; Mototsugu Oya, Tokyo, Japan; Masao Omura, Tetsuo Nishikawa, Yokohama, Japan INTRODUCTION AND OBJECTIVES: Conventional adrenal venous sampling (cAVS) is useful for identifying laterality of primary aldosteronism (PA). In cAVS, plasma cortisol concentration (PCC) is used for normalization of plasma aldosterone concentration (PAC). We have developed a novel super-selective adrenal venous sampling (ssAVS) method using a specialized microcatheter, which collect blood samples from adrenal tributary veins (TVs). PAC in ssAVS samples do not require PCC-normalization since the samples contain a limited amount of systemic venous blood, if any. The ssAVS method enabled us to identify and surgically treat adrenal segments responsible for excess aldosterone production in bilateral PA cases. In this study, we aimed to determine if ssAVS is useful for evaluating cortisol production in a PA case with subclinical Cushing's syndrome (SCS).
METHODS: In the case, ssAVS data was evaluated with clinical and histological data.
RESULTS: A computed tomography identified bilateral adrenal tumors (Fig. 1A) . Right adrenal venography identified superior TV (blue arrow in Fig. 1B ), lateral TV (red) that was downstream of the tumor, and inferior TV (green). Left adrenal venography identified superior-median TV (red arrow in Fig. 1C ) with a filling defect presumably due to the left adenoma (green), superior-lateral TV (blue), and lateral TV (yellow). Blood samples were individually collected from these bilateral TVs by ssAVS. The PCC in right lateral TV (1,150 mg/dL) and PAC in left superior-median TV (30,400 pg/mL) were much higher than the others (indicated in Fig. 1B and 1C) , suggesting that the right and left tumors were a cortisol-producing adenoma (CPA) and aldosterone-producing adenoma, respectively. Left partial adrenalectomy was performed and PA was cured. SCS is currently followed up without treatment, because his SCS has not caused hypertension or impaired glucose tolerance. Pathological diagnosis of left tumor was adrenal adenoma in hematoxylin and eosin staining (T in Fig. 1D ), which was positive for aldosterone synthase (AS, Fig. 1E ) but not for 11b-hydroxylase (11b, cortisol producing enzyme, Fig. 1F ). 11b was negative in adjacent normal adrenal (N in Fig. 1F ), suggesting that cortisol production was suppressed by the possible right CPA. These enzyme expression was consistent with ssAVS data.
CONCLUSIONS: This study suggested that ssAVS is useful for evaluating cortisol production in adrenal adenomas. INTRODUCTION AND OBJECTIVES: Partial Adrenalectomy (PA) has dramatically changed the treatment of patients affected by pathologies that affect both adrenal glands. Currently, evidences regarding the use of PA to treat primary macronodular adrenal hyperplasia(PMAH) are limited, including a small number of cases described as part of cohorts related to a variety of adrenal gland tumors. To date, the outcomes of this surgical treatment on hypercortisolism control is not known. In order to overcome the hormonal replacement caveats while minimizing the risks of hypercortisolism relapse, we performed a series of simultaneous total adrenalectomy of largest adrenal gland and contra-lateral partial adrenalectomy(adrenal sparing surgery) in patients with PMAH.
METHODS: Ten patients diagnosed with PMAH were treated surgically with adrenal sparing surgery. Primary endpoint was hypercortisolism remission, considered when patients had physiologic cortisol levels (5-25 mg/L) without hormonal reposition. Adrenal insufficiency and latent adrenal insufficiency were defined when oral hydrocortisone reposition was needed, with the dose of > 0,2 mg/kg/day and ¼ 0,2 mg/kg/day, respectively.Secondary endpoints were clinical and metabolic parameters improvement. Body mass index (BMI), blood pressure, cholesterol, lipid and glucose levels, were measured before and 12 months after the procedure. Medications to control comorbidities were also assessed and compared.
RESULTS: There were no intra-operative complications and average operation time was 189 AE 34 minutes. Median hospitalization period was 7,5 days and one patient needed surgical hematoma drainage. With a median follow-up of 24 months (range: 13 to 63 months), 40% of the cohort had complete hypercortisolism remission, 20% persisted with latent adrenal insufficiency and 40% with adrenal insufficiency. Hypercortisolism recurrence was not observed. Median systolic/diastolic blood pressures were 155/95 before and 123/80 after the procedure (p < 0,001). Median number of medications to control blood hypertension diminished from 3 to 1(p < 0,001). There was no significant change in cholesterol, lipid and glucose blood levels as well as the number of diabetes and lipid lowering medications. Median BMI decreased from 31,7 AE 7,8 to 28,4 AE 4,7(p ¼ 0.05).
CONCLUSIONS: An early assessment revealed that adrenal sparing surgery is a feasible procedure to treat patients affected by
